JP2020516671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516671A5 JP2020516671A5 JP2019556238A JP2019556238A JP2020516671A5 JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5 JP 2019556238 A JP2019556238 A JP 2019556238A JP 2019556238 A JP2019556238 A JP 2019556238A JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- compound
- acid
- triazole
- sulfanyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 129
- -1 3- (diethylamino) propyl Chemical group 0.000 claims 48
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 33
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 16
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 10
- VDEUYMSGMPQMIK-UHFFFAOYSA-N benzhydroxamic acid Chemical compound ONC(=O)C1=CC=CC=C1 VDEUYMSGMPQMIK-UHFFFAOYSA-N 0.000 claims 9
- 239000002253 acid Substances 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 claims 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000006516 2-(benzyloxy)ethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 2
- GMZWCDSFCCBBAI-UHFFFAOYSA-N 4-[[5-(2-fluorophenyl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound FC1=C(C=CC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO GMZWCDSFCCBBAI-UHFFFAOYSA-N 0.000 claims 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 claims 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 2
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims 2
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 2
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical group C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229930192474 thiophene Chemical group 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims 1
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 claims 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 claims 1
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 claims 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims 1
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 claims 1
- IOQORVDNYPOZPL-VQTJNVASSA-N (5S,6R)-5-(4-chlorophenyl)-6-cyclopropyl-3-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-5,6-dihydro-2H-1,2,4-oxadiazine Chemical compound ClC1=CC=C(C=C1)[C@@H]1NC(=NO[C@@H]1C1CC1)C1=NC(=C(C=C1)N1C=NC(=C1)C)OC IOQORVDNYPOZPL-VQTJNVASSA-N 0.000 claims 1
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- ZYZCALPXKGUGJI-DDVDASKDSA-M (e,3r,5s)-7-[3-(4-fluorophenyl)-2-phenyl-5-propan-2-ylimidazol-4-yl]-3,5-dihydroxyhept-6-enoate Chemical compound C=1C=C(F)C=CC=1N1C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C(C)C)N=C1C1=CC=CC=C1 ZYZCALPXKGUGJI-DDVDASKDSA-M 0.000 claims 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical group C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 claims 1
- FZQXMGLQANXZRP-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-3-(3-imidazol-1-ylpropyl)thiourea Chemical compound C1=C(OC)C(OC)=CC=C1NC(=S)NCCCN1C=NC=C1 FZQXMGLQANXZRP-UHFFFAOYSA-N 0.000 claims 1
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 claims 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 claims 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 claims 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims 1
- 125000000134 2-(methylsulfanyl)ethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])[*] 0.000 claims 1
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 claims 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 claims 1
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 claims 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims 1
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 claims 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- XQQBUAPQHNYYRS-UHFFFAOYSA-N 2-methylthiophene Chemical group CC1=CC=CS1 XQQBUAPQHNYYRS-UHFFFAOYSA-N 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- MDRPNGAGPUOFPA-UHFFFAOYSA-N 3,5-difluoro-4-[[4-(4-fluorophenyl)-5-(piperidin-1-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C1=CC=C(C=C1)F)CN1CCCCC1)F)C(=O)NO MDRPNGAGPUOFPA-UHFFFAOYSA-N 0.000 claims 1
- VRDGWNVYPNEZML-UHFFFAOYSA-N 3,5-difluoro-4-[[4-(furan-2-ylmethyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C=1C=NC=CC=1)F)C(=O)NO VRDGWNVYPNEZML-UHFFFAOYSA-N 0.000 claims 1
- RHZJAJYSZPVEIW-UHFFFAOYSA-N 3,5-difluoro-4-[[4-(furan-2-ylmethyl)-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)N1CCCC1)F)C(=O)NO RHZJAJYSZPVEIW-UHFFFAOYSA-N 0.000 claims 1
- YOIHDAPDYCUJHM-UHFFFAOYSA-N 3,5-difluoro-4-[[5-(2-fluorophenyl)-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=C(C=CC=C1)F)F)C(=O)NO YOIHDAPDYCUJHM-UHFFFAOYSA-N 0.000 claims 1
- XRAYCVXGTQBWKM-UHFFFAOYSA-N 3,5-difluoro-4-[[5-(4-fluorophenyl)-4-(2-morpholin-4-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CCN1CCOCC1)C1=CC=C(C=C1)F)F)C(=O)NO XRAYCVXGTQBWKM-UHFFFAOYSA-N 0.000 claims 1
- UBDPSCAYEZDVAG-UHFFFAOYSA-N 3,5-difluoro-4-[[5-(furan-2-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1OC=CC=1)F)C(=O)NO UBDPSCAYEZDVAG-UHFFFAOYSA-N 0.000 claims 1
- QBHMLIUTCIQHKA-UHFFFAOYSA-N 3,5-difluoro-4-[[5-(furan-2-yl)tetrazol-1-yl]methyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C=1OC=CC=1)F)C(=O)NO QBHMLIUTCIQHKA-UHFFFAOYSA-N 0.000 claims 1
- KVIGMGRUSRSDGB-UHFFFAOYSA-N 3,5-difluoro-4-[[5-(furan-2-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C(=O)NO)C=C(C=1CN1N=C(N=N1)C=1OC=CC=1)F KVIGMGRUSRSDGB-UHFFFAOYSA-N 0.000 claims 1
- UGUDMXQVODIFJW-UHFFFAOYSA-N 3,5-difluoro-4-[[5-[1-(3-fluorophenyl)cyclopentyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CCCC1)C1=CC(=CC=C1)F)F)C(=O)NO UGUDMXQVODIFJW-UHFFFAOYSA-N 0.000 claims 1
- CJGRKGSKAKFUNC-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(4-methyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1C=NC=CC=1)F)C(=O)NO CJGRKGSKAKFUNC-UHFFFAOYSA-N 0.000 claims 1
- PKFOLSOUZPYTPC-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-isoquinolin-1-yltetrazol-1-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=NC=CC2=CC=CC=C12)F)C(=O)NO PKFOLSOUZPYTPC-UHFFFAOYSA-N 0.000 claims 1
- MCQKRHGWAAJJEJ-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-isoquinolin-1-yltetrazol-2-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C1=NC=CC2=CC=CC=C12)F)C(=O)NO MCQKRHGWAAJJEJ-UHFFFAOYSA-N 0.000 claims 1
- UYCATXNNQQDGPV-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC=1OC(=NN=1)C1=CC=CC=C1)F)C(=O)NO UYCATXNNQQDGPV-UHFFFAOYSA-N 0.000 claims 1
- OJELVCJPFBYLMH-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-pyrimidin-2-yltetrazol-1-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=NC=CC=N1)F)C(=O)NO OJELVCJPFBYLMH-UHFFFAOYSA-N 0.000 claims 1
- ZSCIHQFQADRGED-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-quinolin-2-yltetrazol-1-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=NC2=CC=CC=C2C=C1)F)C(=O)NO ZSCIHQFQADRGED-UHFFFAOYSA-N 0.000 claims 1
- WXGQBLNIJTZXJM-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-quinolin-2-yltetrazol-2-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C1=NC2=CC=CC=C2C=C1)F)C(=O)NO WXGQBLNIJTZXJM-UHFFFAOYSA-N 0.000 claims 1
- YSEBLHGDHUUXHS-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1)C=1SC=CC=1)F)C(=O)NO YSEBLHGDHUUXHS-UHFFFAOYSA-N 0.000 claims 1
- JWDMKAQBWAPIKN-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[(5-thiophen-2-yltetrazol-2-yl)methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C=1SC=CC=1)F)C(=O)NO JWDMKAQBWAPIKN-UHFFFAOYSA-N 0.000 claims 1
- YIJBXZDUOXPQPK-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-(1-phenylcyclobutyl)-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CCC1)C1=CC=CC=C1)F)C(=O)NO YIJBXZDUOXPQPK-UHFFFAOYSA-N 0.000 claims 1
- QUIFKTZMXAZFEO-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-(1-pyridin-2-ylcyclopropyl)-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CC1)C1=NC=CC=C1)F)C(=O)NO QUIFKTZMXAZFEO-UHFFFAOYSA-N 0.000 claims 1
- VDKGWVJGSMPFAP-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-(1-pyridin-3-ylcyclopropyl)-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CC1)C=1C=NC=CC=1)F)C(=O)NO VDKGWVJGSMPFAP-UHFFFAOYSA-N 0.000 claims 1
- TZWZUMKATWENRF-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-(2-pyridin-3-ylpropan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C(C)(C=1C=NC=CC=1)C)F)C(=O)NO TZWZUMKATWENRF-UHFFFAOYSA-N 0.000 claims 1
- SQNZQNAKNNZPAU-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-(quinolin-8-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)CC=1C=CC=C2C=CC=NC=12)F)C(=O)NO SQNZQNAKNNZPAU-UHFFFAOYSA-N 0.000 claims 1
- SBFADQWXHBTXKP-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[3-(4-methylpiperazin-1-yl)phenyl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=CC(=CC=C1)N1CCN(CC1)C)F)C(=O)NO SBFADQWXHBTXKP-UHFFFAOYSA-N 0.000 claims 1
- TVVDSGKQYWUWOY-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[3-(4-methylpiperazin-1-yl)sulfonylphenyl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C)F)C(=O)NO TVVDSGKQYWUWOY-UHFFFAOYSA-N 0.000 claims 1
- ISIHLVRMOJXWBE-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[3-(morpholin-4-ylmethyl)phenyl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=CC(=CC=C1)CN1CCOCC1)F)C(=O)NO ISIHLVRMOJXWBE-UHFFFAOYSA-N 0.000 claims 1
- NBUAJLZAQVKMIK-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[3-(piperidin-1-ylmethyl)phenyl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=CC(=CC=C1)CN1CCCCC1)F)C(=O)NO NBUAJLZAQVKMIK-UHFFFAOYSA-N 0.000 claims 1
- UTUAWSCNKHKUFP-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[5-(morpholin-4-ylmethyl)furan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1OC(=CC=1)CN1CCOCC1)F)C(=O)NO UTUAWSCNKHKUFP-UHFFFAOYSA-N 0.000 claims 1
- XUZJZJHLHYMFGX-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[5-(morpholin-4-ylmethyl)furan-3-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=COC(=C1)CN1CCOCC1)F)C(=O)NO XUZJZJHLHYMFGX-UHFFFAOYSA-N 0.000 claims 1
- XGZMXWGZWLKVOZ-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[5-(piperidin-1-ylmethyl)furan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1OC(=CC=1)CN1CCCCC1)F)C(=O)NO XGZMXWGZWLKVOZ-UHFFFAOYSA-N 0.000 claims 1
- MMPYKZTWJVMXFU-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[5-(pyrrolidin-1-ylmethyl)furan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1OC(=CC=1)CN1CCCC1)F)C(=O)NO MMPYKZTWJVMXFU-UHFFFAOYSA-N 0.000 claims 1
- YAEJKUQRIZKKPN-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[5-[(4-methylpiperazin-1-yl)methyl]furan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1OC(=CC=1)CN1CCN(CC1)C)F)C(=O)NO YAEJKUQRIZKKPN-UHFFFAOYSA-N 0.000 claims 1
- IQDIFZUHWJSIJK-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[4-methyl-5-[6-(2-pyrrolidin-1-ylethyl)pyridin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1C=NC(=CC=1)CCN1CCCC1)F)C(=O)NO IQDIFZUHWJSIJK-UHFFFAOYSA-N 0.000 claims 1
- AQMQMNKZLYXPRG-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-(5-morpholin-4-ylpyridin-3-yl)-1,3,4-thiadiazol-2-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CC=1SC(=NN=1)C=1C=NC=C(C=1)N1CCOCC1)F)C(=O)NO AQMQMNKZLYXPRG-UHFFFAOYSA-N 0.000 claims 1
- KZXLLMSNNWGSAH-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-(pyridin-2-ylmethyl)tetrazol-1-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1CC1=NC=CC=C1)F)C(=O)NO KZXLLMSNNWGSAH-UHFFFAOYSA-N 0.000 claims 1
- RDELMWQNFVZMTE-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-(pyridin-2-ylmethyl)tetrazol-2-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)CC1=NC=CC=C1)F)C(=O)NO RDELMWQNFVZMTE-UHFFFAOYSA-N 0.000 claims 1
- KQMYJGXFCFBRJU-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[1-(4-methoxyphenyl)cyclohexyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CCCCC1)C1=CC=C(C=C1)OC)F)C(=O)NO KQMYJGXFCFBRJU-UHFFFAOYSA-N 0.000 claims 1
- OQYMBEMGXVJBGZ-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[1-(4-methoxyphenyl)cyclopropyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1(CC1)C1=CC=C(C=C1)OC)F)C(=O)NO OQYMBEMGXVJBGZ-UHFFFAOYSA-N 0.000 claims 1
- CHTFDUHTFXFYPY-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[3-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-1-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=CC(=CC=C1)S(F)(F)(F)(F)F)F)C(=O)NO CHTFDUHTFXFYPY-UHFFFAOYSA-N 0.000 claims 1
- LUUCPQYOTUFOCI-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[3-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-2-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C1=CC(=CC=C1)S(F)(F)(F)(F)F)F)C(=O)NO LUUCPQYOTUFOCI-UHFFFAOYSA-N 0.000 claims 1
- RCNHCCQIDIQQTQ-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[4-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-1-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=CC=C(C=C1)S(F)(F)(F)(F)F)F)C(=O)NO RCNHCCQIDIQQTQ-UHFFFAOYSA-N 0.000 claims 1
- RDQGHCOUPVCQFW-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[4-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-2-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C1=CC=C(C=C1)S(F)(F)(F)(F)F)F)C(=O)NO RDQGHCOUPVCQFW-UHFFFAOYSA-N 0.000 claims 1
- XUXWOYYRUZQHER-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[4-[methyl(methylsulfonyl)amino]phenyl]-1,3,4-thiadiazol-2-yl]sulfanyl]benzamide Chemical compound FC=1C=C(C=C(C=1SC=1SC(=NN=1)C1=CC=C(C=C1)N(S(=O)(=O)C)C)F)C(=O)NO XUXWOYYRUZQHER-UHFFFAOYSA-N 0.000 claims 1
- BAQYHXGCBRBPKR-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[5-(pyrrolidin-1-ylmethyl)furan-2-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CC1=NOC(=N1)C=1OC(=CC=1)CN1CCCC1)F)C(=O)NO BAQYHXGCBRBPKR-UHFFFAOYSA-N 0.000 claims 1
- ZCKCYMDWFCXIBX-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[5-(trifluoromethyl)pyridin-2-yl]tetrazol-1-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=NN=C1C1=NC=C(C=C1)C(F)(F)F)F)C(=O)NO ZCKCYMDWFCXIBX-UHFFFAOYSA-N 0.000 claims 1
- QCJAURREOKXNGT-UHFFFAOYSA-N 3,5-difluoro-N-hydroxy-4-[[5-[5-(trifluoromethyl)pyridin-2-yl]tetrazol-2-yl]methyl]benzamide Chemical compound FC=1C=C(C=C(C=1CN1N=C(N=N1)C1=NC=C(C=C1)C(F)(F)F)F)C(=O)NO QCJAURREOKXNGT-UHFFFAOYSA-N 0.000 claims 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 claims 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 claims 1
- GQPAXWRYFWUOFN-UHFFFAOYSA-N 3-[2-[[4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]benzoic acid Chemical compound ONC(=O)C1=CC=C(C=C1)CN1N=C(N=N1)C=1C=C(C(=O)O)C=CC=1 GQPAXWRYFWUOFN-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- CDUYFJPDIWPQPP-UHFFFAOYSA-N 4-[(4,5-diphenyl-1,2,4-triazol-3-yl)sulfanyl]-N-hydroxybenzamide Chemical compound C1(=CC=CC=C1)N1C(=NN=C1C1=CC=CC=C1)SC1=CC=C(C=C1)C(=O)NO CDUYFJPDIWPQPP-UHFFFAOYSA-N 0.000 claims 1
- OQBWJRJSJINSGX-UHFFFAOYSA-N 4-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound ONC(=O)c1cc(F)c(Sc2nnc(N3CCOCC3)n2Cc2ccccc2)c(F)c1 OQBWJRJSJINSGX-UHFFFAOYSA-N 0.000 claims 1
- UCBXZMCXVQQVOJ-UHFFFAOYSA-N 4-[(4-benzyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)N1C(=NN=C1C=1SC=CC=1)SC1=C(C=C(C=C1F)C(=O)NO)F UCBXZMCXVQQVOJ-UHFFFAOYSA-N 0.000 claims 1
- PCYHBXKLYGHNDS-UHFFFAOYSA-N 4-[(5-benzhydryl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)(C1=CC=CC=C1)C=1N(C(=NN=1)SC1=C(C=C(C=C1F)C(=O)NO)F)C PCYHBXKLYGHNDS-UHFFFAOYSA-N 0.000 claims 1
- RCGOPOWTQAZTHO-UHFFFAOYSA-N 4-[(5-benzyltetrazol-1-yl)methyl]-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO RCGOPOWTQAZTHO-UHFFFAOYSA-N 0.000 claims 1
- CHNIGSHQRARKPH-UHFFFAOYSA-N 4-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-oxadiazol-2-yl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)CC1=NN=C(O1)C1=CC=C(C=C1)C(=O)NO CHNIGSHQRARKPH-UHFFFAOYSA-N 0.000 claims 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 claims 1
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 claims 1
- LUSBUCOMWZUIOP-UHFFFAOYSA-N 4-[[1-[[2,6-difluoro-4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoic acid Chemical compound FC1=C(C(=CC(=C1)C(NO)=O)F)CN1N=NN=C1CC1=CC=C(C(=O)O)C=C1 LUSBUCOMWZUIOP-UHFFFAOYSA-N 0.000 claims 1
- QAIDGUBGLMYNFX-UHFFFAOYSA-N 4-[[1-[[4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoic acid Chemical compound ONC(=O)C1=CC=C(C=C1)CN1N=NN=C1CC1=CC=C(C(=O)O)C=C1 QAIDGUBGLMYNFX-UHFFFAOYSA-N 0.000 claims 1
- PHDIYKQYARFZSR-UHFFFAOYSA-N 4-[[2-[[2,6-difluoro-4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoic acid Chemical compound FC1=C(C(=CC(=C1)C(NO)=O)F)CN1N=C(N=N1)CC1=CC=C(C(=O)O)C=C1 PHDIYKQYARFZSR-UHFFFAOYSA-N 0.000 claims 1
- GRRGMIBWMGKFDF-UHFFFAOYSA-N 4-[[2-[[4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoic acid Chemical compound ONC(=O)C1=CC=C(C=C1)CN1N=C(N=N1)CC1=CC=C(C(=O)O)C=C1 GRRGMIBWMGKFDF-UHFFFAOYSA-N 0.000 claims 1
- YMVRSRJFUBUMLC-UHFFFAOYSA-N 4-[[2-benzyl-5-(4-chlorophenyl)-1,2,4-triazol-3-yl]methyl]-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)N1N=C(N=C1CC1=CC=C(C=C1)C(=O)NO)C1=CC=C(C=C1)Cl YMVRSRJFUBUMLC-UHFFFAOYSA-N 0.000 claims 1
- WYCMKETXPDPDDN-UHFFFAOYSA-N 4-[[3-[(3,4-dimethoxyphenyl)methyl]-5-thiophen-2-yl-1,2,4-triazol-4-yl]methyl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)CC1=NN=C(N1CC1=CC=C(C=C1)C(=O)NO)C=1SC=CC=1 WYCMKETXPDPDDN-UHFFFAOYSA-N 0.000 claims 1
- SQFCRUKKOCFQTP-UHFFFAOYSA-N 4-[[4-amino-5-[3-(diethylsulfamoyl)phenyl]-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound NN1C(=NN=C1C1=CC(=CC=C1)S(N(CC)CC)(=O)=O)SC1=CC=C(C=C1)C(=O)NO SQFCRUKKOCFQTP-UHFFFAOYSA-N 0.000 claims 1
- MWYSXGSBUCIMQO-UHFFFAOYSA-N 4-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound NN1C(=NN=C1C1=CC=C(C=C1)OC(F)F)SC1=CC=C(C=C1)C(=O)NO MWYSXGSBUCIMQO-UHFFFAOYSA-N 0.000 claims 1
- OPNLIJDFJBQDFQ-UHFFFAOYSA-N 4-[[4-benzyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)N1C(=NN=C1C=1OC=CC=1)SC1=C(C=C(C=C1F)C(=O)NO)F OPNLIJDFJBQDFQ-UHFFFAOYSA-N 0.000 claims 1
- SLXZFQZPDDBHRK-UHFFFAOYSA-N 4-[[4-benzyl-5-(pyrrolidin-1-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound ONC(=O)c1cc(F)c(Sc2nnc(CN3CCCC3)n2Cc2ccccc2)c(F)c1 SLXZFQZPDDBHRK-UHFFFAOYSA-N 0.000 claims 1
- JXAGTYCOYIZUGQ-UHFFFAOYSA-N 4-[[4-ethyl-5-(4-fluorophenyl)-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound C(C)N1C(=NN=C1C1=CC=C(C=C1)F)SC1=CC=C(C=C1)C(=O)NO JXAGTYCOYIZUGQ-UHFFFAOYSA-N 0.000 claims 1
- QUQUSDQDAPUQID-UHFFFAOYSA-N 4-[[5-(1,3-benzodioxol-5-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound O1COC2=C1C=CC(=C2)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C QUQUSDQDAPUQID-UHFFFAOYSA-N 0.000 claims 1
- VWTLMTSFZGOVNA-UHFFFAOYSA-N 4-[[5-(1-benzothiophen-2-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound S1C(=CC2=C1C=CC=C2)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO VWTLMTSFZGOVNA-UHFFFAOYSA-N 0.000 claims 1
- HRHPYDMAIAATJY-UHFFFAOYSA-N 4-[[5-(1-benzothiophen-3-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound S1C=C(C2=C1C=CC=C2)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO HRHPYDMAIAATJY-UHFFFAOYSA-N 0.000 claims 1
- FIMNANSLMVIHGY-UHFFFAOYSA-N 4-[[5-(1-benzyl-4-phenylpiperidin-4-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Cn1c(Sc2c(F)cc(cc2F)C(=O)NO)nnc1C1(CCN(Cc2ccccc2)CC1)c1ccccc1 FIMNANSLMVIHGY-UHFFFAOYSA-N 0.000 claims 1
- WINVBIJCUQMCMZ-UHFFFAOYSA-N 4-[[5-(2,3-dihydro-1,4-benzodioxin-3-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound O1CC(OC2=C1C=CC=C2)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C WINVBIJCUQMCMZ-UHFFFAOYSA-N 0.000 claims 1
- DEFQPMMOLPOQPB-UHFFFAOYSA-N 4-[[5-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Cn1c(Sc2c(F)cc(cc2F)C(=O)NO)nnc1-c1scc2OCCOc12 DEFQPMMOLPOQPB-UHFFFAOYSA-N 0.000 claims 1
- QXIXPEHSCYDHRP-UHFFFAOYSA-N 4-[[5-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)tetrazol-1-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound O1C=2C(OCC1)=C(SC=2)C1=NN=NN1CC1=C(C=C(C(=O)NO)C=C1F)F QXIXPEHSCYDHRP-UHFFFAOYSA-N 0.000 claims 1
- KWQUDGCDOJCMQM-UHFFFAOYSA-N 4-[[5-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound O1C=2C(OCC1)=C(SC=2)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO KWQUDGCDOJCMQM-UHFFFAOYSA-N 0.000 claims 1
- MHFFHARKVRZCBY-UHFFFAOYSA-N 4-[[5-(2,4-dichlorophenyl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound ClC1=C(C=CC(=C1)Cl)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO MHFFHARKVRZCBY-UHFFFAOYSA-N 0.000 claims 1
- ZHWRXLIMCXWAPA-UHFFFAOYSA-N 4-[[5-(2,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound FC1=C(C=CC(=C1)F)C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO ZHWRXLIMCXWAPA-UHFFFAOYSA-N 0.000 claims 1
- YKVDSYRMMKFAHY-UHFFFAOYSA-N 4-[[5-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-3-yl]methyl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)C1=NC(=NO1)CC1=CC=C(C=C1)C(=O)NO YKVDSYRMMKFAHY-UHFFFAOYSA-N 0.000 claims 1
- WKCCDZMYDVMVHJ-UHFFFAOYSA-N 4-[[5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO WKCCDZMYDVMVHJ-UHFFFAOYSA-N 0.000 claims 1
- DOLHDROPQIUIBW-UHFFFAOYSA-N 4-[[5-(4-aminophenyl)tetrazol-1-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Nc1ccc(cc1)-c1nnnn1Cc1c(F)cc(cc1F)C(=O)NO DOLHDROPQIUIBW-UHFFFAOYSA-N 0.000 claims 1
- XBXTYIIDMXYZQN-UHFFFAOYSA-N 4-[[5-(4-aminophenyl)tetrazol-1-yl]methyl]-N-hydroxybenzamide Chemical compound NC1=CC=C(C=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO XBXTYIIDMXYZQN-UHFFFAOYSA-N 0.000 claims 1
- LHBOAIADGXZNHD-UHFFFAOYSA-N 4-[[5-(4-aminophenyl)tetrazol-2-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Nc1ccc(cc1)-c1nnn(Cc2c(F)cc(cc2F)C(=O)NO)n1 LHBOAIADGXZNHD-UHFFFAOYSA-N 0.000 claims 1
- WXNCLPGZPAFVKD-UHFFFAOYSA-N 4-[[5-(4-aminophenyl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound NC1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO WXNCLPGZPAFVKD-UHFFFAOYSA-N 0.000 claims 1
- LPUNNRMWGSBZMU-UHFFFAOYSA-N 4-[[5-(4-chlorophenyl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound ClC1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO LPUNNRMWGSBZMU-UHFFFAOYSA-N 0.000 claims 1
- NXKUCAYUQKFPGR-UHFFFAOYSA-N 4-[[5-(4-fluorophenyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound FC1=CC=C(C=C1)C=1NC(=NN=1)SC1=CC=C(C=C1)C(=O)NO NXKUCAYUQKFPGR-UHFFFAOYSA-N 0.000 claims 1
- IRZGFXCJBZBORR-UHFFFAOYSA-N 4-[[5-(4-fluorophenyl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound FC1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO IRZGFXCJBZBORR-UHFFFAOYSA-N 0.000 claims 1
- KIUYANLPOYKLHJ-UHFFFAOYSA-N 4-[[5-(5-bromopyridin-3-yl)-1,3,4-thiadiazol-2-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound ONC(=O)c1cc(F)c(Sc2nnc(s2)-c2cncc(Br)c2)c(F)c1 KIUYANLPOYKLHJ-UHFFFAOYSA-N 0.000 claims 1
- ZGJLWPCNZQWLGR-UHFFFAOYSA-N 4-[[5-(5-chlorothiophen-2-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound ClC1=CC=C(S1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO ZGJLWPCNZQWLGR-UHFFFAOYSA-N 0.000 claims 1
- DCKAQDQZDMERAL-UHFFFAOYSA-N 4-[[5-(6,6-dimethyl-3-methylsulfanyl-4-oxo-5,7-dihydro-2-benzothiophen-1-yl)tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound CC1(CC(C=2C(=C(SC=2SC)C=2N=NN(N=2)CC2=CC=C(C=C2)C(=O)NO)C1)=O)C DCKAQDQZDMERAL-UHFFFAOYSA-N 0.000 claims 1
- WDPFHXJFRPMVTE-UHFFFAOYSA-N 4-[[5-(furan-2-yl)tetrazol-1-yl]methyl]-N-hydroxybenzamide Chemical compound O1C(=CC=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO WDPFHXJFRPMVTE-UHFFFAOYSA-N 0.000 claims 1
- QNQIDISKSGGWRL-LBPRGKRZSA-N 4-[[5-[(1S)-1-amino-2-(1,3-thiazol-4-yl)ethyl]-1,2,4-oxadiazol-3-yl]methyl]-N-hydroxybenzamide Chemical compound N[C@@H](CC=1N=CSC=1)C1=NC(=NO1)CC1=CC=C(C=C1)C(=O)NO QNQIDISKSGGWRL-LBPRGKRZSA-N 0.000 claims 1
- GJMYJSZRWSWVFY-UHFFFAOYSA-N 4-[[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-oxadiazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)CC1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO GJMYJSZRWSWVFY-UHFFFAOYSA-N 0.000 claims 1
- ZUJMBFPVDVLZPI-UHFFFAOYSA-N 4-[[5-[(3,4-dimethoxyphenyl)methyl]-2-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-3-yl]methyl]-N-hydroxybenzamide Chemical compound COC=1C=C(C=CC=1OC)CC=1N=C(N(N=1)C1=CC=C(C=C1)C(F)(F)F)CC1=CC=C(C=C1)C(=O)NO ZUJMBFPVDVLZPI-UHFFFAOYSA-N 0.000 claims 1
- IBLOHTSZXKCCAW-UHFFFAOYSA-N 4-[[5-[3-(4-benzylpiperazin-1-yl)sulfonylphenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Cn1c(Sc2c(F)cc(cc2F)C(=O)NO)nnc1-c1cccc(c1)S(=O)(=O)N1CCN(Cc2ccccc2)CC1 IBLOHTSZXKCCAW-UHFFFAOYSA-N 0.000 claims 1
- FVPXQKCEJHRCRK-UHFFFAOYSA-N 4-[[5-[3-(azepan-1-ylmethyl)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Cn1c(Sc2c(F)cc(cc2F)C(=O)NO)nnc1-c1cccc(CN2CCCCCC2)c1 FVPXQKCEJHRCRK-UHFFFAOYSA-N 0.000 claims 1
- HTWSGOAKJGRUTD-UHFFFAOYSA-N 4-[[5-[3-(diethylsulfamoyl)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound C(C)N(S(=O)(=O)C=1C=C(C=CC=1)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C)CC HTWSGOAKJGRUTD-UHFFFAOYSA-N 0.000 claims 1
- OIYDIDZWKQULQJ-UHFFFAOYSA-N 4-[[5-[3-(dimethylamino)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound CN(C)c1cccc(c1)-c1nnc(Sc2c(F)cc(cc2F)C(=O)NO)n1C OIYDIDZWKQULQJ-UHFFFAOYSA-N 0.000 claims 1
- BMBUVWIWLFOQIW-UHFFFAOYSA-N 4-[[5-[3-(dimethylamino)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound CN(C=1C=C(C=CC=1)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C)C BMBUVWIWLFOQIW-UHFFFAOYSA-N 0.000 claims 1
- SUHYHACFWDPRSO-UHFFFAOYSA-N 4-[[5-[3-(dimethylsulfamoyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound CN(S(=O)(=O)C=1C=C(C=CC=1)C1=NN=C(O1)CC1=CC=C(C(=O)NO)C=C1)C SUHYHACFWDPRSO-UHFFFAOYSA-N 0.000 claims 1
- SDWOZBLJNQUKAR-UHFFFAOYSA-N 4-[[5-[3-(dimethylsulfamoyl)phenyl]tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound CN(S(=O)(=O)C=1C=C(C=CC=1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO)C SDWOZBLJNQUKAR-UHFFFAOYSA-N 0.000 claims 1
- NLEYXVZVINBVID-UHFFFAOYSA-N 4-[[5-[3-[[benzyl(methyl)amino]methyl]phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound CN(Cc1ccccc1)Cc1cccc(c1)-c1nnc(Sc2c(F)cc(cc2F)C(=O)NO)n1C NLEYXVZVINBVID-UHFFFAOYSA-N 0.000 claims 1
- RFJPORNRXVZSOT-UHFFFAOYSA-N 4-[[5-[4-(aminomethyl)phenyl]tetrazol-1-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound NCc1ccc(cc1)-c1nnnn1Cc1c(F)cc(cc1F)C(=O)NO RFJPORNRXVZSOT-UHFFFAOYSA-N 0.000 claims 1
- QNEYUQKVBLFIGM-UHFFFAOYSA-N 4-[[5-[4-(aminomethyl)phenyl]tetrazol-1-yl]methyl]-N-hydroxybenzamide Chemical compound NCC1=CC=C(C=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO QNEYUQKVBLFIGM-UHFFFAOYSA-N 0.000 claims 1
- DSJRDWLKMOXVKP-UHFFFAOYSA-N 4-[[5-[4-(aminomethyl)phenyl]tetrazol-2-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound NCc1ccc(cc1)-c1nnn(Cc2c(F)cc(cc2F)C(=O)NO)n1 DSJRDWLKMOXVKP-UHFFFAOYSA-N 0.000 claims 1
- FXFZODKSYUPWOG-UHFFFAOYSA-N 4-[[5-[4-(aminomethyl)phenyl]tetrazol-2-yl]methyl]-N-hydroxybenzamide Chemical compound NCC1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO FXFZODKSYUPWOG-UHFFFAOYSA-N 0.000 claims 1
- ZTQAKYGTSIZODA-UHFFFAOYSA-N 4-[[5-[4-(azepan-1-ylmethyl)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound Cn1c(Sc2c(F)cc(cc2F)C(=O)NO)nnc1-c1ccc(CN2CCCCCC2)cc1 ZTQAKYGTSIZODA-UHFFFAOYSA-N 0.000 claims 1
- VDIVEIYQOVQTOR-UHFFFAOYSA-N 4-[[5-[4-(dimethylamino)phenyl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound CN(C1=CC=C(C=C1)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C)C VDIVEIYQOVQTOR-UHFFFAOYSA-N 0.000 claims 1
- ZAHWRWLVUMBRQK-UHFFFAOYSA-N 4-[[5-[5-[bis(2-methoxyethyl)amino]pyridin-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound COCCN(CCOC)c1cncc(c1)-c1nc(Cc2c(F)cc(cc2F)C(=O)NO)no1 ZAHWRWLVUMBRQK-UHFFFAOYSA-N 0.000 claims 1
- ICTKPRAKWXVUDU-UHFFFAOYSA-N 4-[[5-[5-ethyl-4-(pyrrolidin-1-ylmethyl)furan-2-yl]-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-3,5-difluoro-N-hydroxybenzamide Chemical compound CCc1oc(cc1CN1CCCC1)-c1nnc(Sc2c(F)cc(cc2F)C(=O)NO)n1C ICTKPRAKWXVUDU-UHFFFAOYSA-N 0.000 claims 1
- AVKHEVBBPUEMAB-UHFFFAOYSA-N 4-[[5-benzyl-4-(4-fluorophenyl)-1,2,4-triazol-3-yl]sulfanyl]-N-hydroxybenzamide Chemical compound C(C1=CC=CC=C1)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C1=CC=C(C=C1)F AVKHEVBBPUEMAB-UHFFFAOYSA-N 0.000 claims 1
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims 1
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 claims 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 claims 1
- SJFZUTWICLSPIH-UHFFFAOYSA-N 6-[2-[[4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]pyridine-3-carboxylic acid Chemical compound ONC(=O)C1=CC=C(C=C1)CN1N=C(N=N1)C1=CC=C(C=N1)C(=O)O SJFZUTWICLSPIH-UHFFFAOYSA-N 0.000 claims 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 claims 1
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 claims 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 claims 1
- 102000001805 Bromodomains Human genes 0.000 claims 1
- 108050009021 Bromodomains Proteins 0.000 claims 1
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims 1
- BGGALFIXXQOTPY-NRFANRHFSA-N C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC Chemical compound C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC BGGALFIXXQOTPY-NRFANRHFSA-N 0.000 claims 1
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 claims 1
- FJKGOZRGCRRMHY-UHFFFAOYSA-N CN1C(=NN=C1C1=CC(=NC2=CC=CC=C12)C1=CC=C(C=C1)C)SC1=CC=C(C=C1)C(=O)NO Chemical compound CN1C(=NN=C1C1=CC(=NC2=CC=CC=C12)C1=CC=C(C=C1)C)SC1=CC=C(C=C1)C(=O)NO FJKGOZRGCRRMHY-UHFFFAOYSA-N 0.000 claims 1
- NAVYDVVBGLFKKZ-UHFFFAOYSA-N CN1N=C(C=C1C)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C Chemical compound CN1N=C(C=C1C)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C NAVYDVVBGLFKKZ-UHFFFAOYSA-N 0.000 claims 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims 1
- KZTPLUQBNXJBGQ-UHFFFAOYSA-N Cc1cc(nn1C)-c1nnc(Sc2c(F)cc(cc2F)C(=O)NO)n1C Chemical compound Cc1cc(nn1C)-c1nnc(Sc2c(F)cc(cc2F)C(=O)NO)n1C KZTPLUQBNXJBGQ-UHFFFAOYSA-N 0.000 claims 1
- 229940126657 Compound 17 Drugs 0.000 claims 1
- 229940126639 Compound 33 Drugs 0.000 claims 1
- 229940127007 Compound 39 Drugs 0.000 claims 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 1
- IMUQOWIKLQADHX-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC2=CC=CC=C2C=C1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC2=CC=CC=C2C=C1)F)C(=O)NO IMUQOWIKLQADHX-UHFFFAOYSA-N 0.000 claims 1
- PIJSHKHJXZDZRQ-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC=CC2=CC=CC=C12)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC=CC2=CC=CC=C12)F)C(=O)NO PIJSHKHJXZDZRQ-UHFFFAOYSA-N 0.000 claims 1
- ISRCGOUXRYSTNI-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC=CC=C1F)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NC=CC=C1F)F)C(=O)NO ISRCGOUXRYSTNI-UHFFFAOYSA-N 0.000 claims 1
- WLNCPCMYQCSMQV-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NN(C(=C1)C=1SC=CC=1)C1=CC=CC=C1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C1=NN(C(=C1)C=1SC=CC=1)C1=CC=CC=C1)F)C(=O)NO WLNCPCMYQCSMQV-UHFFFAOYSA-N 0.000 claims 1
- ZZXKBCXJYFAEKO-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1N=CC2=CC=CC=C2C=1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1N=CC2=CC=CC=C2C=1)F)C(=O)NO ZZXKBCXJYFAEKO-UHFFFAOYSA-N 0.000 claims 1
- XZAMPYVEQBIWBI-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1N=NC=CC=1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1C)C=1N=NC=CC=1)F)C(=O)NO XZAMPYVEQBIWBI-UHFFFAOYSA-N 0.000 claims 1
- OBLDTPSSRQBNIP-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=CC=NC=C1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=CC=NC=C1)F)C(=O)NO OBLDTPSSRQBNIP-UHFFFAOYSA-N 0.000 claims 1
- RYUWGAYEBOAZMB-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=NC=CC=C1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=NC=CC=C1)F)C(=O)NO RYUWGAYEBOAZMB-UHFFFAOYSA-N 0.000 claims 1
- IKDSPENONMDFEC-UHFFFAOYSA-N FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=NC=CN=C1)F)C(=O)NO Chemical compound FC=1C=C(C=C(C=1SC1=NN=C(N1CC=1OC=CC=1)C1=NC=CN=C1)F)C(=O)NO IKDSPENONMDFEC-UHFFFAOYSA-N 0.000 claims 1
- 102100022537 Histone deacetylase 6 Human genes 0.000 claims 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 1
- 101000899330 Homo sapiens Histone deacetylase 6 Proteins 0.000 claims 1
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 1
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims 1
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims 1
- 102000042838 JAK family Human genes 0.000 claims 1
- 108091082332 JAK family Proteins 0.000 claims 1
- QENGPZGAWFQWCZ-UHFFFAOYSA-N Methylthiophene Chemical group CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- CNZNWHURMCBHOY-SFHVURJKSA-N N-[(1S)-1-[3-[[4-(hydroxycarbamoyl)phenyl]methyl]-1,2,4-oxadiazol-5-yl]-2-(1,3-thiazol-4-yl)ethyl]-3,4-dimethoxybenzamide Chemical compound ONC(=O)C1=CC=C(CC2=NOC(=N2)[C@H](CC=2N=CSC=2)NC(C2=CC(=C(C=C2)OC)OC)=O)C=C1 CNZNWHURMCBHOY-SFHVURJKSA-N 0.000 claims 1
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims 1
- WWGBHDIHIVGYLZ-UHFFFAOYSA-N N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1C1=CC(C(=O)NCCCCCCC(=O)NO)=NO1 WWGBHDIHIVGYLZ-UHFFFAOYSA-N 0.000 claims 1
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims 1
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 claims 1
- PKEKNKLPPWLHQV-UHFFFAOYSA-N N-hydroxy-4-[(2-pyridin-2-yl-5-thiophen-2-yl-1,2,4-triazol-3-yl)methyl]benzamide Chemical compound N1=C(C=CC=C1)N1N=C(N=C1CC1=CC=C(C=C1)C(=O)NO)C=1SC=CC=1 PKEKNKLPPWLHQV-UHFFFAOYSA-N 0.000 claims 1
- MSCFDHCHPPYDNY-UHFFFAOYSA-N N-hydroxy-4-[(3-phenyl-1H-1,2,4-triazol-5-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C=1NC(=NN=1)CC1=CC=C(C=C1)C(=O)NO MSCFDHCHPPYDNY-UHFFFAOYSA-N 0.000 claims 1
- WDVFWXVHRTTWKB-UHFFFAOYSA-N N-hydroxy-4-[(5-isoquinolin-1-yltetrazol-1-yl)methyl]benzamide Chemical compound C1(=NC=CC2=CC=CC=C12)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO WDVFWXVHRTTWKB-UHFFFAOYSA-N 0.000 claims 1
- DZXJHWRZRYDOJK-UHFFFAOYSA-N N-hydroxy-4-[(5-isoquinolin-1-yltetrazol-2-yl)methyl]benzamide Chemical compound C1(=NC=CC2=CC=CC=C12)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO DZXJHWRZRYDOJK-UHFFFAOYSA-N 0.000 claims 1
- OXLNMEDUEZIBFQ-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C1=NC(=NO1)CC1=CC=C(C=C1)C(=O)NO OXLNMEDUEZIBFQ-UHFFFAOYSA-N 0.000 claims 1
- LSOVYTQCGHSENN-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]benzamide Chemical compound C1(=CC=CC=C1)C1=NN=C(O1)NC1=CC=C(C=C1)C(=O)NO LSOVYTQCGHSENN-UHFFFAOYSA-N 0.000 claims 1
- SRYWVVNANVTMSJ-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO SRYWVVNANVTMSJ-UHFFFAOYSA-N 0.000 claims 1
- GRVXTOYDNBLZLW-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]benzamide Chemical compound C1(=CC=CC=C1)C1=NN=C(O1)SC1=CC=C(C=C1)C(=O)NO GRVXTOYDNBLZLW-UHFFFAOYSA-N 0.000 claims 1
- PZLABBVBRVFWHW-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C1=NN=C(S1)CC1=CC=C(C=C1)C(=O)NO PZLABBVBRVFWHW-UHFFFAOYSA-N 0.000 claims 1
- DVAUFTRLDYDKKE-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyltetrazol-1-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO DVAUFTRLDYDKKE-UHFFFAOYSA-N 0.000 claims 1
- GASSJWYDVSUMDF-UHFFFAOYSA-N N-hydroxy-4-[(5-phenyltetrazol-2-yl)methyl]benzamide Chemical compound C1(=CC=CC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO GASSJWYDVSUMDF-UHFFFAOYSA-N 0.000 claims 1
- HLDUGYNYLHPROD-UHFFFAOYSA-N N-hydroxy-4-[(5-pyridin-2-yltetrazol-2-yl)methyl]benzamide Chemical compound N1=C(C=CC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO HLDUGYNYLHPROD-UHFFFAOYSA-N 0.000 claims 1
- SCDJEMXLAMVJGX-UHFFFAOYSA-N N-hydroxy-4-[(5-pyrimidin-2-yltetrazol-1-yl)methyl]benzamide Chemical compound N1=C(N=CC=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO SCDJEMXLAMVJGX-UHFFFAOYSA-N 0.000 claims 1
- PMHARNDBRDSPAO-UHFFFAOYSA-N N-hydroxy-4-[(5-pyrimidin-2-yltetrazol-2-yl)methyl]benzamide Chemical compound N1=C(N=CC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO PMHARNDBRDSPAO-UHFFFAOYSA-N 0.000 claims 1
- XBBPCSKBLKWFFW-UHFFFAOYSA-N N-hydroxy-4-[(5-quinolin-2-yltetrazol-1-yl)methyl]benzamide Chemical compound N1=C(C=CC2=CC=CC=C12)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO XBBPCSKBLKWFFW-UHFFFAOYSA-N 0.000 claims 1
- BSSLAUBSRPDZRV-UHFFFAOYSA-N N-hydroxy-4-[(5-quinolin-2-yltetrazol-2-yl)methyl]benzamide Chemical compound N1=C(C=CC2=CC=CC=C12)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO BSSLAUBSRPDZRV-UHFFFAOYSA-N 0.000 claims 1
- JRSYPNBKQFIMOH-UHFFFAOYSA-N N-hydroxy-4-[(5-thiophen-2-yltetrazol-2-yl)methyl]benzamide Chemical compound S1C(=CC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO JRSYPNBKQFIMOH-UHFFFAOYSA-N 0.000 claims 1
- QFHKETNYWNTIJR-UHFFFAOYSA-N N-hydroxy-4-[[2-(2-methoxyphenyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]methyl]benzamide Chemical compound COC1=C(C=CC=C1)N1N=C(N=C1CC1=CC=C(C=C1)C(=O)NO)C=1SC=CC=1 QFHKETNYWNTIJR-UHFFFAOYSA-N 0.000 claims 1
- QQZVPMKJTQHMRY-UHFFFAOYSA-N N-hydroxy-4-[[3-(1H-indol-3-ylmethyl)-5-thiophen-2-yl-1,2,4-triazol-4-yl]methyl]benzamide Chemical compound N1C=C(C2=CC=CC=C12)CC1=NN=C(N1CC1=CC=C(C(=O)NO)C=C1)C=1SC=CC=1 QQZVPMKJTQHMRY-UHFFFAOYSA-N 0.000 claims 1
- WYOFGNUTZYNRKF-UHFFFAOYSA-N N-hydroxy-4-[[4-methyl-5-[5-[(4-methylpiperazin-1-yl)methyl]furan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound CN1C(=NN=C1C=1OC(=CC=1)CN1CCN(CC1)C)SC1=CC=C(C=C1)C(=O)NO WYOFGNUTZYNRKF-UHFFFAOYSA-N 0.000 claims 1
- JOJOCEJEWKSFQN-UHFFFAOYSA-N N-hydroxy-4-[[5-(2-morpholin-4-ylpyridin-4-yl)-1,2,4-oxadiazol-3-yl]methyl]benzamide Chemical compound O1CCN(CC1)C1=NC=CC(=C1)C1=NC(=NO1)CC1=CC=C(C=C1)C(=O)NO JOJOCEJEWKSFQN-UHFFFAOYSA-N 0.000 claims 1
- IYORVNDUXHAOJX-UHFFFAOYSA-N N-hydroxy-4-[[5-(3-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]benzamide Chemical compound COC=1C=C(C=CC=1)C=1N(C(=NN=1)SC1=CC=C(C=C1)C(=O)NO)C IYORVNDUXHAOJX-UHFFFAOYSA-N 0.000 claims 1
- JKXVUGNMCPTBJH-UHFFFAOYSA-N N-hydroxy-4-[[5-(3-methylthiophen-2-yl)tetrazol-2-yl]methyl]benzamide Chemical compound CC1=C(SC=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO JKXVUGNMCPTBJH-UHFFFAOYSA-N 0.000 claims 1
- IJVMELPEEYLSHL-UHFFFAOYSA-N N-hydroxy-4-[[5-(3-morpholin-4-ylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]methyl]benzamide Chemical compound O1CCN(CC1)S(=O)(=O)C=1C=C(C=CC=1)C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO IJVMELPEEYLSHL-UHFFFAOYSA-N 0.000 claims 1
- DHDHYPUAZBGGRF-UHFFFAOYSA-N N-hydroxy-4-[[5-(3-pyrrolidin-1-ylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]amino]benzamide Chemical compound N1(CCCC1)S(=O)(=O)C=1C=C(C=CC=1)C1=NN=C(O1)NC1=CC=C(C=C1)C(=O)NO DHDHYPUAZBGGRF-UHFFFAOYSA-N 0.000 claims 1
- MWOOVVNOQMCIGO-UHFFFAOYSA-N N-hydroxy-4-[[5-(4-methoxy-3-phenylmethoxyphenyl)tetrazol-1-yl]methyl]benzamide Chemical compound C(C1=CC=CC=C1)OC=1C=C(C=CC=1OC)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO MWOOVVNOQMCIGO-UHFFFAOYSA-N 0.000 claims 1
- DSWJXAMDHUNJNQ-UHFFFAOYSA-N N-hydroxy-4-[[5-(4-methoxy-3-phenylmethoxyphenyl)tetrazol-2-yl]methyl]benzamide Chemical compound C(C1=CC=CC=C1)OC=1C=C(C=CC=1OC)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO DSWJXAMDHUNJNQ-UHFFFAOYSA-N 0.000 claims 1
- OZRBSDXJXYOUQA-UHFFFAOYSA-N N-hydroxy-4-[[5-(4-methoxyphenyl)tetrazol-2-yl]methyl]benzamide Chemical compound COC1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO OZRBSDXJXYOUQA-UHFFFAOYSA-N 0.000 claims 1
- NFWXDBMZWUVWFG-UHFFFAOYSA-N N-hydroxy-4-[[5-(4-methyl-2-morpholin-4-yl-1,3-thiazol-5-yl)-1,3,4-oxadiazol-2-yl]methyl]benzamide Chemical compound CC=1N=C(SC=1C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO)N1CCOCC1 NFWXDBMZWUVWFG-UHFFFAOYSA-N 0.000 claims 1
- RWGAYZRXSMZKIV-UHFFFAOYSA-N N-hydroxy-4-[[5-(4-pyrrolidin-1-ylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]methyl]benzamide Chemical compound N1(CCCC1)S(=O)(=O)C1=CC=C(C=C1)C1=NN=C(O1)CC1=CC=C(C=C1)C(=O)NO RWGAYZRXSMZKIV-UHFFFAOYSA-N 0.000 claims 1
- QYDURSWGVIPMKS-UHFFFAOYSA-N N-hydroxy-4-[[5-(5-methylthiophen-2-yl)tetrazol-2-yl]methyl]benzamide Chemical compound CC1=CC=C(S1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO QYDURSWGVIPMKS-UHFFFAOYSA-N 0.000 claims 1
- XDPMVPBRPWANMC-UHFFFAOYSA-N N-hydroxy-4-[[5-(pyridin-2-ylmethyl)tetrazol-1-yl]methyl]benzamide Chemical compound N1=C(C=CC=C1)CC1=NN=NN1CC1=CC=C(C=C1)C(=O)NO XDPMVPBRPWANMC-UHFFFAOYSA-N 0.000 claims 1
- HQWAKIPRLBXXRT-UHFFFAOYSA-N N-hydroxy-4-[[5-(pyridin-2-ylmethyl)tetrazol-2-yl]methyl]benzamide Chemical compound N1=C(C=CC=C1)CC=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO HQWAKIPRLBXXRT-UHFFFAOYSA-N 0.000 claims 1
- RGPRABLXRYJELS-UHFFFAOYSA-N N-hydroxy-4-[[5-[3-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-2-yl]methyl]benzamide Chemical compound FS(C=1C=C(C=CC=1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO)(F)(F)(F)F RGPRABLXRYJELS-UHFFFAOYSA-N 0.000 claims 1
- ALSSVXSZNBAAGQ-UHFFFAOYSA-N N-hydroxy-4-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]tetrazol-1-yl]methyl]benzamide Chemical compound O1CCN(CC1)C=1C(=NC=C(C=1)C(F)(F)F)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO ALSSVXSZNBAAGQ-UHFFFAOYSA-N 0.000 claims 1
- WZNBNICFSSPSKV-UHFFFAOYSA-N N-hydroxy-4-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]tetrazol-2-yl]methyl]benzamide Chemical compound O1CCN(CC1)C=1C(=NC=C(C=1)C(F)(F)F)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO WZNBNICFSSPSKV-UHFFFAOYSA-N 0.000 claims 1
- SMHKUSCHGUWTJK-UHFFFAOYSA-N N-hydroxy-4-[[5-[4-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-1-yl]methyl]benzamide Chemical compound FS(C1=CC=C(C=C1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO)(F)(F)(F)F SMHKUSCHGUWTJK-UHFFFAOYSA-N 0.000 claims 1
- BCRGDHMYUOBCDM-UHFFFAOYSA-N N-hydroxy-4-[[5-[4-(pentafluoro-lambda6-sulfanyl)phenyl]tetrazol-2-yl]methyl]benzamide Chemical compound FS(C1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO)(F)(F)(F)F BCRGDHMYUOBCDM-UHFFFAOYSA-N 0.000 claims 1
- ZDZCBKYMNKPPMJ-UHFFFAOYSA-N N-hydroxy-4-[[5-[4-(trifluoromethyl)phenyl]tetrazol-2-yl]methyl]benzamide Chemical compound FC(C1=CC=C(C=C1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO)(F)F ZDZCBKYMNKPPMJ-UHFFFAOYSA-N 0.000 claims 1
- OVKHLBYTOCUSCB-UHFFFAOYSA-N N-hydroxy-4-[[5-[5-(trifluoromethyl)pyridin-2-yl]tetrazol-1-yl]methyl]benzamide Chemical compound FC(C=1C=CC(=NC=1)C1=NN=NN1CC1=CC=C(C=C1)C(=O)NO)(F)F OVKHLBYTOCUSCB-UHFFFAOYSA-N 0.000 claims 1
- YCRBHQPLGURVLO-UHFFFAOYSA-N N-hydroxy-4-[[5-[5-(trifluoromethyl)pyridin-2-yl]tetrazol-2-yl]methyl]benzamide Chemical compound FC(C=1C=CC(=NC=1)C=1N=NN(N=1)CC1=CC=C(C=C1)C(=O)NO)(F)F YCRBHQPLGURVLO-UHFFFAOYSA-N 0.000 claims 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- RCIXVFWCNWSUSH-UHFFFAOYSA-N O1C(=CC=C1)CN1C(=NN=C1C1=CNC2=CC=CC=C12)SC1=CC=C(C=C1)C(=O)NO Chemical compound O1C(=CC=C1)CN1C(=NN=C1C1=CNC2=CC=CC=C12)SC1=CC=C(C=C1)C(=O)NO RCIXVFWCNWSUSH-UHFFFAOYSA-N 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 1
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 claims 1
- 125000004171 alkoxy aryl group Chemical group 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 229940125773 compound 10 Drugs 0.000 claims 1
- 229940125797 compound 12 Drugs 0.000 claims 1
- 229940126543 compound 14 Drugs 0.000 claims 1
- 229940125758 compound 15 Drugs 0.000 claims 1
- 229940126142 compound 16 Drugs 0.000 claims 1
- 229940125782 compound 2 Drugs 0.000 claims 1
- 229940125810 compound 20 Drugs 0.000 claims 1
- 229940126086 compound 21 Drugs 0.000 claims 1
- 229940125833 compound 23 Drugs 0.000 claims 1
- 229940125961 compound 24 Drugs 0.000 claims 1
- 229940125846 compound 25 Drugs 0.000 claims 1
- 229940125851 compound 27 Drugs 0.000 claims 1
- 229940127204 compound 29 Drugs 0.000 claims 1
- 229940126214 compound 3 Drugs 0.000 claims 1
- 229940125877 compound 31 Drugs 0.000 claims 1
- 229940125878 compound 36 Drugs 0.000 claims 1
- 229940125807 compound 37 Drugs 0.000 claims 1
- 229940127573 compound 38 Drugs 0.000 claims 1
- 229940126540 compound 41 Drugs 0.000 claims 1
- 229940125936 compound 42 Drugs 0.000 claims 1
- 229940125844 compound 46 Drugs 0.000 claims 1
- 229940127271 compound 49 Drugs 0.000 claims 1
- 229940125898 compound 5 Drugs 0.000 claims 1
- 229940126545 compound 53 Drugs 0.000 claims 1
- 229940127113 compound 57 Drugs 0.000 claims 1
- 229940125900 compound 59 Drugs 0.000 claims 1
- 229940126179 compound 72 Drugs 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 claims 1
- 230000001973 epigenetic effect Effects 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims 1
- 229940043355 kinase inhibitor Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- UMSATGPAFSLMNK-UHFFFAOYSA-N methyl 4-[[1-[[2,6-difluoro-4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoate Chemical compound FC1=C(C(=CC(=C1)C(NO)=O)F)CN1N=NN=C1CC1=CC=C(C(=O)OC)C=C1 UMSATGPAFSLMNK-UHFFFAOYSA-N 0.000 claims 1
- WMBDECBTGHWCIK-UHFFFAOYSA-N methyl 4-[[2-[[2,6-difluoro-4-(hydroxycarbamoyl)phenyl]methyl]tetrazol-5-yl]methyl]benzoate Chemical compound FC1=C(C(=CC(=C1)C(NO)=O)F)CN1N=C(N=N1)CC1=CC=C(C(=O)OC)C=C1 WMBDECBTGHWCIK-UHFFFAOYSA-N 0.000 claims 1
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 claims 1
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 claims 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims 1
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- 239000003207 proteasome inhibitor Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000004523 tetrazol-1-yl group Chemical group N1(N=NN=C1)* 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 125000004360 trifluorophenyl group Chemical group 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022164773A JP2022191395A (ja) | 2017-04-14 | 2022-10-13 | 選択的hdac6阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000041723 | 2017-04-14 | ||
| IT102017000041723A IT201700041723A1 (it) | 2017-04-14 | 2017-04-14 | Nuovi inibitori selettivi di HDAC6 |
| PCT/EP2018/059468 WO2018189340A1 (en) | 2017-04-14 | 2018-04-12 | Selective hdac6 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164773A Division JP2022191395A (ja) | 2017-04-14 | 2022-10-13 | 選択的hdac6阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516671A JP2020516671A (ja) | 2020-06-11 |
| JP2020516671A5 true JP2020516671A5 (enExample) | 2020-12-17 |
| JP7241025B2 JP7241025B2 (ja) | 2023-03-16 |
Family
ID=59700099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556238A Active JP7241025B2 (ja) | 2017-04-14 | 2018-04-12 | 選択的hdac6阻害剤 |
| JP2022164773A Withdrawn JP2022191395A (ja) | 2017-04-14 | 2022-10-13 | 選択的hdac6阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164773A Withdrawn JP2022191395A (ja) | 2017-04-14 | 2022-10-13 | 選択的hdac6阻害剤 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US11351178B2 (enExample) |
| EP (1) | EP3562810B1 (enExample) |
| JP (2) | JP7241025B2 (enExample) |
| KR (1) | KR102525375B1 (enExample) |
| CN (1) | CN110546140B (enExample) |
| AR (1) | AR111466A1 (enExample) |
| AU (1) | AU2018252172B9 (enExample) |
| CA (1) | CA3056381A1 (enExample) |
| CL (1) | CL2019002869A1 (enExample) |
| CO (1) | CO2019011993A2 (enExample) |
| CY (1) | CY1126110T1 (enExample) |
| DK (1) | DK3562810T3 (enExample) |
| ES (1) | ES2951476T3 (enExample) |
| FI (1) | FI3562810T3 (enExample) |
| HR (1) | HRP20230789T8 (enExample) |
| HU (1) | HUE063079T2 (enExample) |
| IL (1) | IL268955B (enExample) |
| IT (1) | IT201700041723A1 (enExample) |
| LT (1) | LT3562810T (enExample) |
| MX (1) | MX2019011876A (enExample) |
| NZ (1) | NZ756603A (enExample) |
| PE (1) | PE20200446A1 (enExample) |
| PL (1) | PL3562810T3 (enExample) |
| PT (1) | PT3562810T (enExample) |
| RS (1) | RS64376B1 (enExample) |
| RU (1) | RU2764718C2 (enExample) |
| SI (1) | SI3562810T1 (enExample) |
| SM (1) | SMT202300228T1 (enExample) |
| TW (1) | TWI813564B (enExample) |
| WO (1) | WO2018189340A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| CN109942564A (zh) * | 2019-04-16 | 2019-06-28 | 四川大学华西医院 | 一种组蛋白去乙酰化酶抑制剂及其制备方法和用途 |
| CN115443329A (zh) | 2019-06-27 | 2022-12-06 | 乔治华盛顿大学国会特许非营利公司 | Hdac6激活的巨噬细胞、其组合物及用途 |
| WO2021013163A1 (en) * | 2019-07-23 | 2021-01-28 | Taipei Medical University | Histone deacetylase 6 inhibitors and method for treating neuropathic pain |
| AU2020407664A1 (en) * | 2019-12-20 | 2022-08-18 | Tenaya Therapeutics, Inc. | Fluoroalkyl-oxadiazoles and uses thereof |
| IL300389A (en) | 2020-08-07 | 2023-04-01 | Italfarmaco Spa | New oxadiazole-based selective HDAC6 inhibitors |
| CN112250638B (zh) * | 2020-11-13 | 2022-05-03 | 郑州大学 | 一种1,3-二芳基-1,2,4-三氮唑类化合物及其制备方法和应用 |
| IT202100009926A1 (it) | 2021-04-20 | 2022-10-20 | Italfarmaco Spa | Una combinazione comprendente un inibitore di hdac6 specifico e almeno un inibitore del checkpoint ctla4 |
| TW202340480A (zh) | 2021-11-23 | 2023-10-16 | 義大利商義大利藥品股份有限公司 | 檢測rna生物標記之方法 |
| WO2023219456A1 (ko) * | 2022-05-12 | 2023-11-16 | 숙명여자대학교 산학협력단 | 퀴놀린 계열 히스톤디아세틸화 효소 저해활성물질, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물 |
| EP4595976A1 (en) * | 2022-09-27 | 2025-08-06 | Samsung Life Public Welfare Foundation | Composition for treating cancer containing histone deacetylase inhibitor, and anticancer adjuvant for cancer immunotherapy |
| CN115611823B (zh) * | 2022-10-27 | 2024-09-27 | 新天地医药技术研究院(郑州)有限公司 | 一种1,2,4-三氮唑-苯基异羟肟酸类化合物、制备方法和应用 |
| CN115737549A (zh) * | 2022-11-24 | 2023-03-07 | 北京鑫开元医药科技有限公司 | 一种具有hdac抑制活性的注射液及其制备方法和用途 |
| IL321862A (en) * | 2023-01-06 | 2025-08-01 | Sparrow Pharmaceuticals Inc | Methods and compounds for treating disorders caused by HSD-1 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2473510A1 (en) | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives as rho-kinase inhibitors |
| JP2008504345A (ja) | 2004-07-02 | 2008-02-14 | ノボ ノルディスク アクティーゼルスカブ | コンデンスチオフェン誘導体(condensedthiophenederivatives)およびそれらのサイクリックGLP−1アゴニストとしての使用 |
| GB0607899D0 (en) | 2006-04-03 | 2006-05-31 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
| US20090005374A1 (en) | 2007-06-26 | 2009-01-01 | Melvin Jr Lawrence S | Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| WO2010151318A1 (en) | 2009-06-22 | 2010-12-29 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| CN102548975A (zh) * | 2009-07-07 | 2012-07-04 | 安瑟生物科技私人有限公司 | 组蛋白去乙酰化酶抑制剂 |
| JP5518397B2 (ja) | 2009-08-12 | 2014-06-11 | 富士フイルム株式会社 | 水性インク組成物、複合粒子の製造方法、インクセット、及び、画像形成方法 |
| WO2011106650A2 (en) | 2010-02-27 | 2011-09-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| US8614223B2 (en) * | 2010-11-16 | 2013-12-24 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| WO2012106343A2 (en) * | 2011-02-01 | 2012-08-09 | The Board Of Trustees Of The University Of Illinois | Hdac inhibitors and therapeutic methods using the same |
| EP2487159A1 (en) | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
| WO2012178208A2 (en) * | 2011-06-24 | 2012-12-27 | The Trustees Of The Stevens Institute Of Technology | Selective inhibitors of histone deacetylase isoform 6 and methods thereof |
| TR201900057T4 (tr) | 2013-12-12 | 2019-01-21 | Chong Kun Dang Pharmaceutical Corp | Selektif histon deasetilaz (HDAC) inhibitörleri olarak yeni azaindol deriveleri ve bunları içeren farmasötik bileşimler. |
| KR101685639B1 (ko) | 2014-01-03 | 2016-12-12 | 주식회사 종근당 | 신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| CN106456580B (zh) * | 2014-05-14 | 2020-09-04 | 科罗拉多州立大学董事会法人团体 | 作为蛋白质脱乙酰酶抑制剂和蛋白质脱乙酰酶-蛋白质激酶双重抑制剂的杂环异羟肟酸及其使用方法 |
| WO2015192078A1 (en) * | 2014-06-12 | 2015-12-17 | Cedars-Sinai Medical Center | Compositions and methods for treating cancers |
-
2017
- 2017-04-14 IT IT102017000041723A patent/IT201700041723A1/it unknown
-
2018
- 2018-04-09 TW TW107112124A patent/TWI813564B/zh active
- 2018-04-12 ES ES18716299T patent/ES2951476T3/es active Active
- 2018-04-12 PE PE2019001995A patent/PE20200446A1/es unknown
- 2018-04-12 CN CN201880024895.9A patent/CN110546140B/zh active Active
- 2018-04-12 CA CA3056381A patent/CA3056381A1/en active Pending
- 2018-04-12 HU HUE18716299A patent/HUE063079T2/hu unknown
- 2018-04-12 EP EP18716299.5A patent/EP3562810B1/en active Active
- 2018-04-12 PT PT187162995T patent/PT3562810T/pt unknown
- 2018-04-12 SI SI201830949T patent/SI3562810T1/sl unknown
- 2018-04-12 MX MX2019011876A patent/MX2019011876A/es unknown
- 2018-04-12 HR HRP20230789TT patent/HRP20230789T8/hr unknown
- 2018-04-12 NZ NZ756603A patent/NZ756603A/en unknown
- 2018-04-12 JP JP2019556238A patent/JP7241025B2/ja active Active
- 2018-04-12 RS RS20230576A patent/RS64376B1/sr unknown
- 2018-04-12 LT LTEPPCT/EP2018/059468T patent/LT3562810T/lt unknown
- 2018-04-12 FI FIEP18716299.5T patent/FI3562810T3/fi active
- 2018-04-12 DK DK18716299.5T patent/DK3562810T3/da active
- 2018-04-12 SM SM20230228T patent/SMT202300228T1/it unknown
- 2018-04-12 US US16/491,827 patent/US11351178B2/en active Active
- 2018-04-12 WO PCT/EP2018/059468 patent/WO2018189340A1/en not_active Ceased
- 2018-04-12 PL PL18716299.5T patent/PL3562810T3/pl unknown
- 2018-04-12 AU AU2018252172A patent/AU2018252172B9/en active Active
- 2018-04-12 KR KR1020197033482A patent/KR102525375B1/ko active Active
- 2018-04-12 RU RU2019132212A patent/RU2764718C2/ru active
- 2018-04-13 AR ARP180100940A patent/AR111466A1/es unknown
-
2019
- 2019-08-27 IL IL268955A patent/IL268955B/en unknown
- 2019-10-08 CL CL2019002869A patent/CL2019002869A1/es unknown
- 2019-10-28 CO CONC2019/0011993A patent/CO2019011993A2/es unknown
-
2022
- 2022-10-13 JP JP2022164773A patent/JP2022191395A/ja not_active Withdrawn
-
2023
- 2023-07-26 CY CY20231100364T patent/CY1126110T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516671A5 (enExample) | ||
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| JP2019517455A5 (enExample) | ||
| JP5674828B2 (ja) | Pde10インヒビターならびに関連する組成物および方法 | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| JP2010533158A5 (enExample) | ||
| JP2018535999A5 (enExample) | ||
| JP2014511869A5 (enExample) | ||
| JP2017505762A5 (enExample) | ||
| JP2016164184A5 (enExample) | ||
| RU2018138707A (ru) | Замещенные гетероарилом пиридины и способы применения | |
| JP2014525444A5 (enExample) | ||
| IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| JP2007510689A5 (enExample) | ||
| JP2008546836A (ja) | 新規な用途 | |
| JP2007530690A5 (enExample) | ||
| JP2019518036A5 (enExample) | ||
| JP2010505809A5 (enExample) | ||
| JP2010510242A5 (enExample) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| JP2007523208A5 (enExample) | ||
| JP2006503081A5 (enExample) | ||
| JP2010513438A5 (enExample) | ||
| JP2018507234A5 (enExample) |